DNLI vs STZ · rev $3.6M vs P/E 14, rev $9.14B
Denali Therapeutics Inc (DNLI) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported DNLI revenue for 2026-06-30 was $3.6M. Net income was -$256.0M. DNLI currently screens at market cap $2.11B.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
DNLI currently screens at market cap $2.11B. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the DNLI and STZ stock pages for the full models.
Not investment advice.